Thomas Engstrøm

Clinical outcomes of no stenting in patients with ST-segment elevation myocardial infarction undergoing deferred primary percutaneous coronary intervention

Madsen J, Kelbæk H, Nepper-Christensen L, Jacobsen MR, Ahtarovski KA, Høfsten D, Holmvang L, Pedersen F, Tilsted H, Aarøe J, Jensen SE, Raungaard B, Terkelsen C, Køber L, Engstrøm T, Lønborg JT

March 16, 2022 | 10.4244/EIJ-D-21-00950

Diagnostic performance of angiography-based fractional flow reserve by patient and lesion characteristics

Kobayashi Y, Collet C, Achenbach S, Engstrøm T, Assali A, Shlofmitz R, Fournier S, Kirtane A, Ali Z, Kornowski R, Leon M, De Bruyne B, Fearon W

July 20, 2021 | 10.4244/EIJ-D-19-00933

Selective intracoronary hypothermia in patients with ST-elevation myocardial infarction. Rationale and design of the EURO-ICE trial

El Farissi M, Keulards D, van 't Veer M, Zelis J, Berry C, De Bruyne B, Engstrøm T, Fröbert O, Piroth Z, Oldroyd K, Tonino P, Pijls N, Otterspoor L

April 20, 2021 | 10.4244/EIJ-D-19-00471

Five-year clinical outcomes of zotarolimus-eluting stents in coronary total occlusions

Kelbæk H, Yeh R, Engstrøm T, Neumann F, Serruys P, Windecker S, Belardi J, Qiao S, Xu B, Liu M, Silber S

March 19, 2021 | 10.4244/EIJ-D-19-00866

Fractional flow reserve-guided PCI in patients with and without left ventricular hypertrophy: a DANAMI-3-PRIMULTI substudy

Sabbah M, Nepper-Christensen L, Lønborg J, Helqvist S, Køber L, Høfsten D, Ahtarovski KA, Göransson C, Kyhl K, Schoos M, Vejlstrup N, Kelbæk H, Engstrøm T

September 18, 2020 | 10.4244/EIJ-D-19-00577

Myocardial damage after ST-segment elevation myocardial infarction by use of bivalirudin or heparin: a DANAMI-3 substudy

Schoos M, Nepper-Christensen L, Ahtarovski KA, Kyhl K, Göransson C, Holmvang L, Kelbæk H, Helqvist S, Høfsten D, Køber L, Vejlstrup N, Lønborg J, Engstrøm T

April 3, 2020 | 10.4244/EIJ-D-19-00623

Characterisation of lesions undergoing ischaemia-driven revascularisation after complete revascularisation versus culprit lesion only in patients with STEMI and multivessel disease: a DANAMI-3-PRIMULTI substudy

De Backer O, Lønborg J, Helqvist S, Warnøe J, Kløvgaard L, Holmvang L, Pedersen F, Tilsted H, Raungaard B, Jørgensen E, Køber L, Høfsten D, Kelbæk H, Engstrøm T

June 20, 2019 | 10.4244/EIJ-D-18-00766

Intravascular assessment of coronary arteries in patients with cyanotic congenital heart disease

Tarp JB, Radu M, De Backer O, Jensen A, Celermajer D, Sorensen K, Holstein-Rathlou N-H, Engstrøm T, Søndergaard L

April 16, 2019 | 10.4244/EIJ-D-18-00882

Ten-year clinical outcome of patients treated with a drug-eluting stent in the proximal left anterior descending artery segment compared with patients stented in other non-left main coronary segments

Kjoller-Hansen L, Bligaard N, Kelbæk H, Christiansen E, Thuesen L, Hansen PR, Engstrøm T, Junker A, Abildgaard U, Lassen J, Jensen JS, Jeppesen JL, Galloe A

September 20, 2018 | 10.4244/EIJ-D-18-00396

Impact of diagnostic ECG-to-wire delay in STEMI patients treated with primary PCI: a DANAMI-3 substudy

Nepper-Christensen L, Lønborg J, Hofsten D, Ahtarovski KA, Kyhl K, Göransson C, Køber L, Helqvist S, Pedersen F, Kelbæk H, Vejlstrup N, Holmvang L, Engstrøm T

August 24, 2018 | 10.4244/EIJ-D-17-00857

Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation: too early to draw conclusions

Lønborg J, Engstrøm T, De Backer O, Søndergaard L

August 3, 2018 | 10.4244/EIJV14I5A85

The Compare-Acute trial of fractional flow reserve-guided multivessel angioplasty in myocardial infarction

Chin C, L’Allier P, Neumann F, Engstrøm T, Jüni P, Olivecrona G

August 4, 2017 | 10.4244/EIJV13I5A96

To defer, or not to defer, that is the question

Kelbæk H, Hofsten D, Engstrøm T

July 20, 2017 | 10.4244/EIJV13I4A58

Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality: a Swedish nationwide observational study

Mohammad M, Andell P, Koul S, Desta L, Jernberg T, Omerovic E, Spaak J, Fröbert O, Jensen J, Engstrøm T, Hofman-Bang C, Persson H, Erlinge D

June 2, 2017 | 10.4244/EIJ-D-16-01021

Selective use of contemporary drug-eluting stents in primary angioplasty for ST-elevation myocardial infarction: pooled analysis of COMFORTABLE AMI and EXAMINATION

Baumbach A, Heg D, Räber L, Ostoijc M, Brugaletta S, Strange J, Johnson TW, Jüni P, Engstrøm T, Serruys P, Sabaté M, Windecker S

January 20, 2017 | 10.4244/EIJ-D-15-00408

Bleeding episodes in “complete, staged” versus “culprit only” revascularisation in patients with multivessel disease and ST-segment elevation myocardial infarction: a DANAMI-3-PRIMULTI substudy

Sadjadieh G, Engstrøm T, Helqvist S, Hofsten D, Køber L, Pedersen F, Clemmensen P, Jørgensen E, Saunamäki K, Tilsted H, Kelbæk H, Holmvang L

November 20, 2016 | 10.4244/EIJV12I10A203

A post hoc analysis of long-term prognosis after exenatide treatment in patients with ST-segment elevation myocardial infarction

Kyhl K, Lønborg J, Vejlstrup N, Kelbæk H, Helqvist S, Holmvang L, Jørgensen E, Saunamäki K, Bøtker H, Clemmensen P, Køber L, Treiman M, Engstrøm T

July 20, 2016 | 10.4244/EIJV12I4A78

Long-term outcome of FFR-guided PCI for stable coronary artery disease in daily clinical practice: a propensity score-matched landmark analysis

De Backer O, Biasco L, Lønborg J, Pedersen F, Holmvang L, Kelbæk H, Arnous S, Saunamäki K, Helqvist S, Kastrup J, Jørgensen E, Engstrøm T

February 12, 2016 | 10.4244/EIJV11I11A247

Optimal catchment area and primary PCI centre volume revisited: a single-centre experience in transition from high-volume centre to “mega centre” for patients with ST-segment elevation myocardial infarction

Schoos M, Pedersen F, Holmvang L, Engstrøm T, Saunamäki K, Helqvist S, Kastrup J, Mehran R, Dangas G, Jørgensen E, Kelbæk H, Clemmensen P

September 22, 2015 | 10.4244/EIJY14M11_07

ST peak during percutaneous coronary intervention serves as an early prognostic predictor in patients with ST-segment elevation myocardial infarction

Lønborg J, Kelbæk H, Engstrøm T, Helqvist S, Kløvgaard L, Holmvang L, Vejlstrup N, Jørgensen E, Saunamäki K, Dridi N, Kaltoft A, Bøtker H, Clemmensen P, Terkelsen C

August 19, 2014 | 10.4244/EIJV10I4A80

Thomas Engstrøm

Latest news